Critical Comparison: ReWalk Robotics (LFWD) vs. Its Rivals

ReWalk Robotics (NASDAQ:LFWDGet Free Report) is one of 48 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its competitors? We will compare ReWalk Robotics to related companies based on the strength of its institutional ownership, profitability, valuation, dividends, risk, analyst recommendations and earnings.

Volatility & Risk

ReWalk Robotics has a beta of 2.02, suggesting that its stock price is 102% more volatile than the S&P 500. Comparatively, ReWalk Robotics’ competitors have a beta of 0.90, suggesting that their average stock price is 10% less volatile than the S&P 500.

Earnings & Valuation

This table compares ReWalk Robotics and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
ReWalk Robotics $13.85 million -$22.13 million -1.82
ReWalk Robotics Competitors $1.49 billion $157.84 million 23.36

ReWalk Robotics’ competitors have higher revenue and earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and recommmendations for ReWalk Robotics and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReWalk Robotics 0 0 1 0 3.00
ReWalk Robotics Competitors 340 1174 2276 98 2.55

ReWalk Robotics presently has a consensus price target of $21.00, suggesting a potential upside of 301.53%. As a group, “Surgical appliances & supplies” companies have a potential upside of 3.65%. Given ReWalk Robotics’ stronger consensus rating and higher probable upside, research analysts plainly believe ReWalk Robotics is more favorable than its competitors.

Insider & Institutional Ownership

26.8% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 46.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by insiders. Comparatively, 9.3% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.


This table compares ReWalk Robotics and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ReWalk Robotics -159.76% -28.19% -23.29%
ReWalk Robotics Competitors -30.53% -65.13% -12.00%


ReWalk Robotics competitors beat ReWalk Robotics on 8 of the 13 factors compared.

ReWalk Robotics Company Profile

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with's FREE daily email newsletter.